Danaher Corporation (DHR) Stock Grade

About Danaher Corporation's fundamentals

Danaher is a large-cap healthcare diagnostics and research company with a $161.9 billion market capitalization that generated 2.9% year-over-year revenue growth and maintains a healthy 14.7% net profit margin. The company's valuation is notably elevated at a P/E ratio of 44.8, reflecting market expectations for future performance. However, return on equity stands at a modest 6.9%, suggesting limited efficiency in generating returns from shareholder capital, while the 0.6% dividend yield indicates the company prioritizes reinvestment over cash distributions to investors.